Desire for information about drugs: Relationships with patients' characteristics and adverse effects

Pharmacy World and Science

Volumn 24, Issue 5, 2002, Pages 205-210

  Laaksonen, R ^a   Duggan, C ^a   Bates, I ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adverse drug effects; Drug information; EID (extent of information desired) scale; Information need; Medicines management

Indexed keywords

ANTIBIOTIC AGENT; ATENOLOL; COTRIMOXAZOLE; FUSIDATE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE;

ADULT; AGED; ALGORITHM; ALLERGY; ARTICLE; DRUG INFORMATION; FEMALE; HIGH RISK POPULATION; HUMAN; INTERVIEW; INVOLUNTARY MOVEMENT; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT INFORMATION; RASH; RATING SCALE; RELIABILITY; SCAR; STOMACH HEMORRHAGE; UNITED KINGDOM; VALIDATION PROCESS; WHEEZING;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; DRUG INFORMATION SERVICES; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PHARMACEUTICAL PREPARATIONS; PHYSICIAN-PATIENT RELATIONS;

EID: 0036797453     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020542502118     Document Type: Article

References (26)

1. Leape L, Brennan T, Laird N, Lawthers A, Localio A, Barnes B, et al. The nature of adverse events in hospitalized patients: Results of the Harvard medical practice study II. (1991) N Engl J Med 1991;324:377-84.
2. Martys C. Adverse reactions to drugs in general practice. BMJ 1979;619:1194-7.
3. Classen D, Pestotnik S, Evans R, Lloyd J, Burke J. Adverse drug events in hospitalized patients. J Am Med Assoc 1997;277:301-6.
4. Department of Health. An Organisation with a Memory, London: HMSO, 2000.
5. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969;634:536-9.
6. Bennett B, Lipman A. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 1977;34:931-6.
7. Mannesse C, Derkx F, Ridder M, Cammen T, Veld A. Adverse drug reactions in elderly patients as contributing factor for hospital admission: Cross sectional study. BMJ 1997;315:1057-8.
8. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999;33:236-40.
9. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998;45:301-8.
10. Hurwitz N. Admissions to hospital due to drugs. BMJ 1969;643:539-40.
11. Martínez-Mir I, García-López M, Palop V, Ferrer J, Estañ L, Rubio E, Morales-Olivas F. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996;42:319-24.
12. Koch K. Use of standardized screening procedures to identify adverse drug reactions. Am J Hosp Pharm 1990;47:1314-20.
13. Azaz-Livshits T, Levy M, Sadan B, Shalit M, Geisslinger G, Brune K. Computerized surveillance of adverse drug reactions in hospital: Pilot study. Br J Clinl Pharmacol 1998;45:309-14.
14. Karch F, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Therapeutics 1977;21:247-54.
15. Kramer M, Leventhal J, Hutchinson T, Feinstein A. An algorithm for the operational assessment of adverse drug reactions. I: Background, description, and instructions for use. J Am Med Assoc 1979;242:623-32.
16. Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E, Janecek E, Domecq C, Greenblatt D. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Therapeutics 1981;30:239-47.
17. Michel D, Knodel L. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986;43:1709-14.
18. Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 1992;2:356-67.
19. O'Brien B, Elswood J, Calin A. Perception of drug risks: A survey of patients with ankylosing spondylitis. J Rheumatol 1990;17:503-7
20. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: Is the information good enough? BMJ 1999;318:318-20.
21. Busson M, Dunn A. Patients' knowledge about prescribed medicines. Pharmaceut J 1986;236:624-6.
22. Gibbs S, Waters W, George C. Communicating information to patients about medicine. J R Soc Med 1990;83:292-7.
23. Duggan C, Bates I. Development and evaluation of a survey tool to explore patients' perceptions of their prescribed drugs and their need for drug information. Int J Pharm Pract 2000;8:42-52.
24. Åström K, Carlsson J, Bates I, Webb D, Duggan C, Sanghani P, McRobbie D. Desire for information about drugs: A multimethod study in general medical inpatients. Pharm World Sci 2000;22:159-64.
25. British National Formulary March 2000. The British Medical Association and the Royal Pharmaceutical Society of Great Britain.
26. Wood S, Vere D. Clinical pharmacology and general patient care in two teaching hospitals. J R Soc Med 1980;73:355-8.